FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054160 [Registered on: 20/06/2023] Trial Registered Prospectively
Last Modified On: 17/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study of Gunja taila on Migraine. 
Scientific Title of Study   Clinical evaluation of Gunja tail Nasya in Ardhavabhedaka (Migraine). 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swati Bhatt 
Designation  PG Scholar 
Affiliation  Gurukul Campus, Uttrakhand Ayurved University, Haridwar 
Address  Department of Panchkarma Gurukul Campus, Uttrakhand Ayurved University, Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9761008941  
Fax    
Email  dr.swatibhatt2405@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Uttam Kumar Sharma 
Designation  Professor and HOD 
Affiliation  Gurukul Campus, Uttrakhand Ayurved University, Haridwar 
Address  Department of Panchkarma, Gurukul Campus, Uttrakhand Ayurved University, Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9411149479  
Fax    
Email  druksm27@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Uttam Kumar Sharma 
Designation  Professor and HOD 
Affiliation  Gurukul Campus, Uttrakhand Ayurved University, Haridwar 
Address  Department of Panchkarma, Gurukul Campus, Uttrakhand Ayurved University, Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9411149479  
Fax    
Email  druksm27@gmail.com  
 
Source of Monetary or Material Support  
Gurukul Campus, Uttrakhand Ayurved University, Haridwar 249404 
 
Primary Sponsor  
Name  Gurukul Campus Uttrakhand Ayurved University Haridwar 
Address  Gurukul Campus, Uttrakhand Ayurved University, Haridwar 249404 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swati Bhatt  Gurukul Campus Uttarakhand Ayurveda University Haridwar  OPD no. 24 Department of Panchakrma Haridwar Uttarakhand
Hardwar
UTTARANCHAL 
9761008941

dr.swatibhatt2405@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
UTTARAKHAND AYURVED UNIVERSITY, DEHRADUN Office of the Campus Director/ Principal Gurukul Campus, Haridwar- 249404  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G439||Migraine, unspecified. Ayurveda Condition: ARDHAVABHEDAKA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gunja Taila, Reference: Bhaishajya Ratnavali Shirorogadhikara Ch. 65/153-156, Route: Nasal, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 4(ml), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 33 Days, Reference: No, Route: -, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Intervention ArmDrugOther than Classical(1) Medicine Name: Roasted wheat powder capsules, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 33 Days, anupAna/sahapAna: Yes(details: water), Additional Information: Group B- Placebo control group oral administration of roasted wheat powder capsules 1 capsule (500mg) BD.
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Age group 16-60 years.
2.Patient will be selected irrespective of sex,religion,occupation,habitat etc.
3.Patient with any classical symptoms of Ardhavabhedak/Migraine.
4.Patient having recurrent attack of headache with or without nausea,vomiting,aura.
5.Patient fit for Nasya karma. 
 
ExclusionCriteria 
Details  1.Patient unfit for Nasya karma as mentioned in Ayurvedic reference books.
2.Patient having history of Head Trauma.
3.Pregnant women and Lactating mothers.
4.Patient having symptoms of Ophthalmoplegic migraine and Retinal migraine.
5.Known cause of headache like epilepsy, cysticercosis, brain tumor.
6.Systemic disorders that may interfere in the line of treatment like heart disease, kidney disease, hyperthyroidism, hypothyroidism.
7.Secondary headache caused by meningitis, tumor, encephalitis, cervical spondylitis, refractive errors and infectious disease.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement will be assessed on the basis of
subjective parameters- by Grading scale adopted for this study and MIDAS SCALE. 
Outcome will be assessed at baseline, 33 day, 48 day and 63 day 
 
Secondary Outcome  
Outcome  TimePoints 
T.L.C
D.L.C
E.S.R
R.B.S
Urine examination- Routine and microscopic 
At baseline and 33 day. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   03/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Ardhavabhedaka is a type of Shiro-rog, characterised by severe tearing and pricking pain in Manya, Bhru, Shankha, Karna, Akshi and Lalata which is paroxysmal in nature and is very much resembles to Migraine. In Bhaisajyaratnavali, Acharya Govinddas Sen has indicated Gunja Taila nasya in Ardhavabhedaka. In this study we will administered Gunja Taila as Nasya in Group A and Placebo (Roasted wheat powder capsules) in Group B. 
Close